fosinopril has been researched along with Liver Cirrhosis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abdallah, HM; El-Batran, SA; El-Demerdash, E; Salam, OM; Shaffie, NM | 1 |
| De Girolamo, V; Guerriero, C; Loguercio, C; Piscopo, P; Valese, C | 1 |
2 other study(ies) available for fosinopril and Liver Cirrhosis
| Article | Year |
|---|---|
Inhibition of the renin-angiotensin system attenuates the development of liver fibrosis and oxidative stress in rats.
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Antioxidants; Carbon Tetrachloride; Disease Models, Animal; Dose-Response Relationship, Drug; Fosinopril; Glutathione; Hydroxyproline; Lipid Peroxidation; Lisinopril; Liver; Liver Cirrhosis; Liver Function Tests; Losartan; Male; Oxidative Stress; Rats; Renin-Angiotensin System | 2008 |
[Evaluation of the total hepatic function after treatment with fosinopril in hypertensive patients with liver cirrhosis].
Topics: Fosinopril; Humans; Hypertension; Liver; Liver Cirrhosis; Liver Function Tests; Male; Middle Aged | 1994 |